Quantum Diamonds, Tokyo, and Genetics

QuantumDiamonds, a company specializing in quantum sensing technology, has raised €7 million in Seed funding. The company focuses on developing atom-sized quantum sensors, capable of nano-scale imaging of magnetic fields, making them highly sensitive and useful for various applications, including semiconductor manufacturing and medical diagnostics. With a working prototype already in place, QuantumDiamonds plans to use the investment to expand its team of quantum engineers and work towards its first commercial product.

Researchers at Texas A&M University have utilized quantum computing to advance genetic research, discovering previously unknown links between genes. This breakthrough in gene regulatory networks (GRNs) mapping offers more accurate predictions of gene interactions, which is vital for both human and animal medicine. Quantum computing allows for processing more complex genetic relationships than traditional computing methods, which typically compare only two genes at a time.

Oxford Quantum Circuits (OQC) has announced a $100 million Series B round, led by Japan's premier VC firm SBI Investment. This marks the largest Series B funding in the UK's quantum computing sector. The company also launched OQC Toshiko, the first enterprise-ready quantum computing platform, catering to industries that handle sensitive data.